$18.60 3.2%
AVNS Stock Price vs. AI Score
Data gathered: November 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Avanos Medical

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.


Avanos Medical
Price $18.60
Target Price Sign up
Volume 347,230
Market Cap $821M
Year Range $17.8 - $24.69
Dividend Yield 0%
PE Ratio 38.02
Analyst Rating 0% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24170M158M93M4.3M18M0.360
Q2 '24172M163M96M1.8M13M0.290
Q1 '24162M161M95M-900,0009.3M0.190
Q4 '2399M128M95M11M18M0.320
Q3 '23167M161M96M-3.7M13M0.420

Insider Transactions View All

Greiner Michael filed to sell 151,495 shares at $19.2.
March 15 '24
Greiner Michael filed to sell 152,413 shares at $19.1.
March 15 '24
Greiner Michael filed to sell 154,981 shares at $19.1.
March 15 '24
Greiner Michael filed to sell 151,605 shares at $19.2.
March 15 '24
Greiner Michael filed to sell 152,750 shares at $19.1.
March 15 '24

What is the Market Cap of Avanos Medical?

The Market Cap of Avanos Medical is $821M.

What is Avanos Medical's PE Ratio?

As of today, Avanos Medical's PE (Price to Earnings) ratio is 38.02.

What is the current stock price of Avanos Medical?

Currently, the price of one share of Avanos Medical stock is $18.60.

How can I analyze the AVNS stock price chart for investment decisions?

The AVNS stock price chart above provides a comprehensive visual representation of Avanos Medical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Avanos Medical shares. Our platform offers an up-to-date AVNS stock price chart, along with technical data analysis and alternative data insights.

Does AVNS offer dividends to its shareholders?

As of our latest update, Avanos Medical (AVNS) does not offer dividends to its shareholders. Investors interested in Avanos Medical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Avanos Medical?

Some of the similar stocks of Avanos Medical are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.